The expenditure on medical and diagnostic laboratories in Belgium has shown significant fluctuations over the past decade. From a low of 1.44 Euros Per Capita in 2014, the spending peaked at 4.72 Euros Per Capita in 2021. The growth was particularly notable between 2017 and 2020, with double-digit year-on-year increases. However, the trend reversed after 2021, with a sharp drop in 2022 and continued declines till 2023 where spending stood at 2.83 Euros Per Capita.

The projected data from 2024 to 2028 indicates a slight downward trend, with the expenditure expected to stabilize around 2.79-2.82 Euros Per Capita. The 5-year CAGR forecast starting from 2024 indicates a marginal decline of -0.21%, signaling a balanced but slightly shrinking expenditure.

The key trends to watch in the future include:

Potential impact of technological advancements in diagnostics which may either drive costs down or spur higher expenditures due to new, expensive innovations.
Changes in healthcare policies or funding that could significantly alter spending dynamics.
The long-term effects of the COVID-19 pandemic, including ongoing requirements for virus testing and other diagnostic services.